https://www.phe.gov/ASPRBlog/pages/BlogArticlePage.aspx?PostID=345

FDA Authorizes Marketing of a BARDA-funded Diagnostic Test to Detect the Zika Virus in Human Blood The first commercially available Zika virus diagnostic blood test, a product BARDA supported through its advanced research and development program, received authorization for marketing from the U.S. Food and Drug Administration (FDA) last month. The test provides results in about four hours. Called the ZIKV Detect 2.0 IgM Capture ELISA, the test exemplifies the progress that is possible with public-private partnerships.

Learn More